Immunovant Appoints Rita Jain Chief Medical Officer And Provides Corporate Update

    NEXT STORY
    Predictive Oncology Announces Closing of $3.074 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
    PREV STORY
    NGM Bio Outlines 2021 Strategic Priorities Across Its Three Therapeutic Area Portfolios, Including Liver and Metabolic Diseases, Retinal Diseases and Oncology
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Athenex, Inc. Reports Fourth Quarter and Year Ended December 31, 2019 Financial Results and Provides Corporate Update

    author_avatar
    NASDAQ Market News

    Asterias Biotherapeutics Announces $10.4 Million Registered Direct Offering

    FREMONT, Calif., Oct. 16, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American:AST), a ...

    author_avatar
    NASDAQ Market News

    Molecular Partners Confirms Retained Activity of Ensovibep on the Positions Mutated in Emerging Omicron Variant of SARS-CoV-2 In Vitro

    author_avatar
    NASDAQ Market News